Venture-Backed Startups
125,316 companies with verified investor relationships.
0 investors
0 investors
BioOrbit produces pharmaceutical-grade crystals in microgravity environments via space-based facilities, enabling development of biologic drugs and treatments for patients. The company bridges orbital research with terrestrial medicine to make advanced pharmaceutical manufacturing accessible beyond hospital settings.
8 investors
Bioplastix engineers E. coli and Halomonas bacteria using AI, enzyme optimization, and precision fermentation to produce high-performance PLA and PHB biopolymers from low-cost sugars and agroindustrial waste. It acts as a technology partner for petrochemical companies, agribusinesses, and consumer goods manufacturers, providing custom microbial strains, biopolymer formulations, and bioprocesses for bioplastic production.
1 investor
BioProtect develops a balloon spacer used in radiation therapy to create uniform anterior-posterior spacing and reduce radiation dose to surrounding tissue during treatments such as prostate cancer radiotherapy. Positioned as the first non-gel spacer for modern radiation therapies, it targets physicians and patients undergoing hypofractionated and SBRT treatments.
4 investors
Bio Protocol is a decentralized science (DeSci) platform where people can fund, develop and govern tokenized early-stage scientific research from universities, companies and researchers. It offers token-based fundraising, staking rewards, and a scientific AI agent framework, supporting an ecosystem of biotech DAOs focused on areas such as longevity, women's health, and rare diseases.
5 investors
Bio Site is a link-in-bio website builder that lets creators build a personalized page using drag-and-drop templates, sell products, book clients, manage affiliates, accept tips and payments via Stripe or PayPal, capture email and phone contacts, and track built-in analytics. It targets social media creators looking to earn income from their audience.
1 investor
Distributor of scientific instrumentation and laboratory consumables serving food and beverage manufacturers, production, and materials science customers across Australia and New Zealand. Offers equipment and services for physical and chemical characterisation, life science, sample preparation, and general lab needs.
1 investor
Bio Usawa is a biotechnology company that develops and manufactures affordable monoclonal antibodies and biologic medicines, with a focus on bringing cancer and other therapies to patients in Africa and globally.
0 investors
0 investors
Supplier of 400+ research-use monoclonal antibodies serving academic, government, and commercial research customers worldwide.
1 investor
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Biomaterials startup developing next-generation regenerative implants; closed a seed round led by Cocoon Capital.
1 investor
BioAegis Therapeutics is a clinical-stage biotech developing therapies for infectious and non-infectious inflammatory diseases based on a recombinant human form of plasma gelsolin (rhu-pGSN), a blood protein that regulates the immune response. Its platform aims to restore depleted gelsolin levels to control inflammation without suppressing immune function.
0 investors
BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue. It targets breast cancer survivors who have undergone mastectomies and lost their nipples, operating in the biomaterials and medical device field.
5 investors
0 investors
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.
7 investors
BioAgilytix is a bioanalytical contract research organization that provides assay development and laboratory testing services supporting drug studies. It serves global pharmaceutical and biotech companies as well as agricultural biotechnology firms, offering scientific and regulatory support across study phases.
1 investor
BioAlert offers the LP15 automated monitoring system that continuously detects Legionella bacteria in cooling towers using qPCR technology, delivering same-day results without manual sampling. It serves industrial operators, real estate managers, and other facility teams to prevent Legionnaires' disease outbreaks and maintain regulatory compliance.
1 investor